Results 111 to 120 of about 41,221 (142)
Some of the next articles are maybe not open access.
Multiple Sclerosis and Related Disorders, 2019
Natalizumab (NTZ) is a highly efficacious therapeutic for multiple sclerosis (MS), but treatment is associated with an increased risk of progressive multifocal leukoencephalopathy (PML). Extended interval dosing (EID) of NTZ has been proposed as an alternative dosing strategy to reduce PML risk. Pharmacokinetic (PK) and pharmacodynamic (PD) profiles of
Susan Goelz, John F Foley
exaly +3 more sources
Natalizumab (NTZ) is a highly efficacious therapeutic for multiple sclerosis (MS), but treatment is associated with an increased risk of progressive multifocal leukoencephalopathy (PML). Extended interval dosing (EID) of NTZ has been proposed as an alternative dosing strategy to reduce PML risk. Pharmacokinetic (PK) and pharmacodynamic (PD) profiles of
Susan Goelz, John F Foley
exaly +3 more sources
Omeprazole: Extended-Interval Dosing (Alternate-Day Dosing)
Hospital Pharmacy, 2006Off-Label Drug Uses This Hospital Pharmacy feature is extracted from Off-Label DrugFacts, a quarterly publication available from Wolters Kluwer Health. Off-Label DrugFacts is a practitioner-oriented resource for information about specific FDA-unapproved drug uses. This new guide to the literature will enable the
Joyce Generali, Dennis J. Cada
openaire +1 more source
Lovastatin: Extended-Interval (Alternate-Day) Dosing
Hospital Pharmacy, 2001Off-Label Drug Uses This Hospital Pharmacy feature is extracted from Off-Label DrugFacts, a quarterly publication available from Facts and Comparisons. Off-Label DrugFacts is a practitioner-oriented resource for information about specific FDA-unapproved drug uses.
Joyce Generali, Dennis J. Cada
openaire +1 more source
Extended-interval dosing of aminoglycosides.
The Mount Sinai journal of medicine, New York, 1998Aminoglycosides are efficacious agents. Their use has declined partly because of the development of newer, presumably less toxic agents. Research shows that aminoglycosides can be dosed differently than in the past, maintaining efficacy while reducing aminoglycoside toxicities. Aminoglycosides administered with newer agents may help overcome antibiotic
M E, Blam, G S, Hammer
openaire +1 more source
Annals of Pharmacotherapy, 2004
BACKGROUND: Gram-positive osteomyelitis requires long-term antibiotic therapy, much of which is often administered in the outpatient setting. Historically, synergistic aminoglycoside use in these infections requires multiple daily doses, which can be inconvenient.
A Christie, Graham +3 more
openaire +2 more sources
BACKGROUND: Gram-positive osteomyelitis requires long-term antibiotic therapy, much of which is often administered in the outpatient setting. Historically, synergistic aminoglycoside use in these infections requires multiple daily doses, which can be inconvenient.
A Christie, Graham +3 more
openaire +2 more sources
Extended-interval dosing of natalizumab in NOVA
The Lancet Neurology, 2023Olaf, Stüve, Bastian, Tugemann
openaire +2 more sources
Two nomograms for determining extended-dosing intervals for gentamicin in neonates
American Journal of Health-System Pharmacy, 2008The development of two nomograms to predict dosing intervals for gentamicin in neonates based on one gentamicin concentration is described.Pooled data from three retrospective studies on neonates age seven days or younger were used to create nomograms that would predict dosing intervals for gentamicin.
John E, Murphy, Anthony M, Roether
openaire +2 more sources
Extended-Interval dosing of tobramycin in neonates: Implications for therapeutic drug monitoring
Clinical Pharmacology & Therapeutics, 2002Our objective was to individualize tobramycin dosing regimens in neonates of various gestational ages with use of early therapeutic drug monitoring.This study was performed in neonatal patients with suspected septicemia in the first week of life. All patients received tobramycin, 4 mg/kg per dose, as a 30-minute intravenous infusion, with a gestational
de Hoog, Matthijs +4 more
openaire +2 more sources
Extended interval gentamicin dosing in obstetrics
American Journal of Obstetrics and Gynecology, 2023Li C, Hardy E, Moreno K
openaire +1 more source
Extended-interval dosing of natalizumab in NOVA – Authors' reply
The Lancet Neurology, 2023John F, Foley +2 more
openaire +2 more sources